European Archives - Page 459 of 1018 - European Medical Journal

Could Artificial Intelligence Shortcuts Misdiagnose COVID-19?

ARTIFICIAL intelligence (AI) is emerging as a promising innovative technique that may soon become an essential part of the diagnosis and treatment of disease. New evidence, however, has surfaced revealing the danger of disease misdiagnosis by clinical AI models.

EMJ Podcast: Hiking to Health

This week, Jonathan contends with Cotswold Way, discussing the bucolic bliss of the trail as he reminds us of the health advantages of walking; including the benefits for our immune system, weight control, sleep cycle, and mental health.

Interview: Philip Newsome

I think the underlying ethos of the ILC is that we want to bring together people who have an interest in improving the outcome of patients with liver disease…

EMJ Hepatology 9.1 Feature Image

Prevalence and Prognostic Value of Cirrhotic Cardiomyopathy as Defined According with the Proposed New Classification

The prevalence and prognostic relevance of cirrhotic cardiomyopathy (CCM), as defined according with the new core criteria proposed in 2019…

EMJ Hepatology 9.1 Feature Image

Review of International Liver Congress 2021

PICTURESQUE Geneva, Switzerland, encircling Lac Léman with the famous Jet d’Eau fountain and overlooked by the Alps, would have…

EMJ Hepatology 9.1 Feature Image

EMJ Hepatology 9.1 2021

Welcome to the latest issue of EMJ Hepatology! Included is an impressive collection of the latest research, alongside our review of the 56th annual International Liver Congress (ILC), hosted online by the European Association for Study of the Liver (EASL). Highlights, interviews, and breaking news from this virtual event are shared in this issue.

Interview: Thomas Berg

The truth is my interest and fascination for liver and hepatology was very much influenced by my father…

EMJ Hepatology 9.1 Feature Image

Referral of Patients with Non-alcoholic Fatty Liver Disease with Significant Fibrosis from Primary Care to Secondary Care in Belgium

Non-alcoholic fatty liver disease (NAFLD) is becoming the most frequent cause of chronic liver disease worldwide. The stage of fibrosis…

EMJ Hepatology 9.1 Feature Image

Gene Editing to Treat Hypercholesterolaemia and Primary Hyperoxaluria

THE INTERNATIONAL Liver Congress (ILC) 2021 of the The European Association for the Study of the Liver (EASL) invited three speakers…

EMJ Hepatology 9.1 Feature Image

Editor’s Pick: Elevated Glucagon in a Patient with Necrolytic Acral Erythema: A Case Report and Review of the Literature

Necrolytic acral erythema (NAE) was first described in 1996 by el Darouti and Abu el Ela in Egypt.1 It is most…